Advertisement
Advertisement
U.S. markets close in 2 hours 12 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Else Nutrition Holdings Inc. (BABYF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.4405-0.0120 (-0.83%)
As of 1:18PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.4525
Open1.3500
BidN/A x N/A
AskN/A x N/A
Day's Range1.3500 - 1.4600
52 Week Range1.0800 - 4.0000
Volume93,995
Avg. Volume216,073
Market Cap153.356M
Beta (5Y Monthly)2.16
PE Ratio (TTM)N/A
EPS (TTM)-0.1760
Earnings DateJun 01, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BABYF

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ELSE NUTRITION HOLDINGS INC
    KNSL: Raising target price to $226.00KINSALE CAPITAL GROUP INC has an Investment Rating of HOLD; a target price of $226.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more
  • GlobeNewswire

    Independent Pilot Research Survey Demonstrates Else Products Dramatically Improved Major Feeding Related Disorders & Symptoms in Large Majority of Children

    A more comprehensive study at final stages is aimed to be published in a peer reviewed medical journalIndependent pilot survey conducted among U.S. moms using Else Nutrition products with their children revealed dramatic improvement with up to complete recovery with feeding-related disorders and symptoms, including gastrointestinal problems, vomiting, skin rashes, spit up, and abnormal growthInitial analysis of the pilot data demonstrated over three quarters of mothers reported that the gastroin

  • GlobeNewswire

    Else to Expand Sales into Europe with Amazon

    VANCOUVER, British Columbia, Nov. 18, 2021 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) ("Else" or the "Company") the plant-based baby, toddler and children nutrition company, is pleased to report on its Amazon progress and plans: Following its stellar success on Amazon in the US, Else was recently invited by Amazon EU to launch a European unified account that will allow Else to sell its unique products on all of Amazon European marketplaces including the UK, Germany

  • GlobeNewswire

    Else Nutrition Receives Conditional Approval to Graduate to the Toronto Stock Exchange

    VANCOUVER, British Columbia, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Else Nutrition Holdings Inc. (TSXV: BABY) (OTCQX: BABYF) (FSE: 0YL) (the “Company” or “Else”), is pleased to announce it has received conditional approval to list its common shares and warrants on the Toronto Stock Exchange (“TSX”). Final approval of the TSX listing is subject to the Company meeting certain customary conditions of the TSX on or before January 20, 2022. Upon receiving final approval from the TSX, Else intends to issue

Advertisement
Advertisement